Viewing Study NCT01492920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-06-13 @ 5:47 AM
Study NCT ID: NCT01492920
Status: WITHDRAWN
Last Update Posted: 2014-12-31
First Post: 2011-12-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Sponsor: Gynecologic Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fatigue View
None Malignant Ovarian Mixed Epithelial Tumor View
None Neuropathy View
None Neurotoxicity Syndrome View
None Ovarian Brenner Tumor View
None Ovarian Clear Cell Cystadenocarcinoma View
None Ovarian Endometrioid Adenocarcinoma View
None Ovarian Mucinous Cystadenocarcinoma View
None Ovarian Serous Cystadenocarcinoma View
None Pain View
None Recurrent Fallopian Tube Carcinoma View
None Recurrent Ovarian Carcinoma View
None Recurrent Primary Peritoneal Carcinoma View
Keywords: